Probiotics Market Size & Share 2025 - 2034

Probiotics Market Size

The global probiotics market size was valued at USD 72.1 billion in 2024. The market is expected to grow from USD 79.2 billion in 2025 to USD 165.1 billion in 2034, at a CAGR of 8.5%, according to latest report published by Global Market Insights Inc.
 

• Probiotics are live microorganisms which provide health benefits to those consuming them in adequate dosage. Awareness about gut health and immune support has increased the demand for probiotics in the world. The rise of the probiotics market has brought with a number of key drivers. These include natural aggregate depletion or depleted resources, making resource conservation mandates important for pushing manufacturers into seeking alternate eco-friendly raw materials and production processes instead of utilizing finite natural resources.
   
• Modernization of infrastructures and booming development in construction enabling manufacturers to adopt advanced, energy-efficient production infrastructures while minimizing the impact on the environment. Such modernized infrastructures improve production operations and help to accomplish global sustainability goals, thereby supporting growth in the long run. This is coupled with cost advantages against natural extraction, which would then encourage companies to innovate and invest in sustainable manufacturing.
   
• Currently, North America is the leading region adopting probiotics underpinned by the advanced manufacturing infrastructure and supportive regulatory environment. On the other hand, the Asia-Pacific region propels itself as the fastest-growing market, elevated by increasing consumer awareness, urbanization, and investments in innovative production technologies.
   

Probiotics Market Trends

• With the breakthrough in genomics and fermentation technologies, scientists expect to create next-generation probiotics with greater survivability, health benefits, and stability. This means that probiotics will increasingly be tailored towards specific health problems and ultimately drive product efficacy and consumer trust. Governments and other agencies are increasingly sponsoring efforts to develop clear guidelines regarding the safety, efficacy, and quality of probiotic products. Consumers are now departing from general probiotic medicine and into demands for functional foods introducing probiotics and custom diets prepared according to microbiome analysis. There is increasingly more knowledge about gut-brain-immune health and, thus, products.
   
• Novel encapsulation and delivery methods are being opted by most manufacturers for the improvement of probiotic stability during the processing, storage, and gastrointestinal transit stages. It helps in the microencapsulation process and lyophilization or using new types of packaging to decrease degradation of products, thus extending shelf life, bringing safety to the consumer, and improving product efficiency.
   
• The development of probiotic research and product development into a digital sphere, aided by digital tools, constructed using data analytics and AI, includes strain screening and clinical testing, in addition to personalized recommendations. Consumer engagement in digital platforms is also being worked on for increased educational platforms toward the sought-after value of probiotic solutions.
   

Probiotics Market Analysis

Based on ingredients, probiotics market is segmented into bacterial probiotics and yeast probiotics. Bacterial probiotics generated USD 64 billion in 2024.
 

• Bacterial probiotics include an array of genera, such as lactobacillus, bifidobacterium, and streptococcus, in addition to strains, akkermansia and faecalibacterium. In the past, this segment was mainly dominated by lactobacillus species. However, due to taxonomic revisions, reclassification has relegated several species under the genera of lactiplantibacillus, lacticaseibacillus, and limosilactobacillus. These bacteria have demonstrated ability in a number of health indicators, including gastro-intestinal health, immunity, and metabolic wellness, backed by clinical studies and regulatory approval over a long period of time.
   
• Yeast probiotics mainly driven by applications of saccharomyces boulardii. Such advantages include high stability through the challenge conditions, the ability to resist antibiotics thereby allowing concurrent therapeutic application, and efficacy for certain indications, like antibiotic-associated diarrhea and clostridium difficile infection, are in place for another push for this sector.
   
• The yolk formulation will significantly restrain the growth due to conjectured major factors like lesser strain diversity than that in bacteria and consumer favoring traditional bacterial preparations. However, increasing clinical findings around yeast probiotics support their availability in unique applications and unique stability characteristics, a feature favoring further growth, especially in clinical and therapeutic markets.
   

Based on application, the probiotics market is segmented into human dietary supplements, functional foods & beverages, animal nutrition & feed applications, pharmaceutical & medical products and others. Human dietary supplements made up 44.7% of the market in 2024.
 

• Human dietary supplements dominates due to consumers opting for convenient, concentrated formats for the delivery of probiotics. This segment includes capsules, tablets, powders, or liquid preparations for daily supplementation. Growth in health consciousness and older populations with digestive problems are a few of the growth drivers along with clinical evidence supporting probiotics for health conditions.
   
• Functional foods and beverages comprises yogurt, fermented milks, probiotic-functioning beverages, as well as novel food matrices that include live cultures. Growth in this area is driven by consumer orientation towards delivery of nutrition via food, integrating probiotics within the daily diet.
   
• Research and development are focusing on non-dairy products, enhanced taste, and longer shelf life. Advances in food processing and packaging technologies have allowed probiotic incorporation into various product categories.
   
• Animal nutrition and feed application growing with the rising stringent restrictions on the use of antibiotic growth promoters in livestock production, demand for antibiotic-free livestock products, and thus the growing market for such products, the demand that created the ground for the segment is the one seeking alternative antibiotic growth promoters for livestock. Probiotic feed additives are known to provide benefits in the area of digestive health enhancement, feed conversion efficiency improvement, and a decrease in the pathogen colonization of livestock.
   
• While pharmaceutical and medical addresses several specialized therapeutic applications. This includes prescription probiotic formulations, medical foods, and the large area of live biotherapeutic products currently being researched as clinical applications.
   

Based on end use industry, the probiotics market is segmented into food & beverage manufacturing, pharmaceutical & biotechnology, animal agriculture & feed, consumer health & wellness and others.
 

• Food and beverage manufacturing including those companies integrating probiotics into consumer food products. The industry hosts dairy processors, beverage producers, functional food manufacturing companies, and specialized nutrition companies.
   
• The pharmaceutical and biotechnology represents all organizations that establish the therapeutic application of probiotics, including pharmaceutical companies studying live biotherapeutic products, biotechnology firms developing novel strains of probiotics, and companies conducting clinical research for medical uses.
   
• Animal agriculture and feeds include the use of probiotics in livestock and aquaculture operations. The feed production industry includes livestock producers and aquaculture operations that use probiotic feed additives for animal health and performance benefits.
   
• Health and wellness companies, including dietary supplement manufacturers, direct-to-consumer wellness brands, and personal nutrition companies. This market is for consumer-facing probiotic products intended for health maintenance and wellness applications.
   

The probiotics market in North America will grow at a CAGR from approximately 8.6% between 2025 and 2034.
 

• The primary factors driving market growth are the increasing awareness among consumers regarding gut health and immune support and rising probiotic application in functional foods and dietary supplements. Innovations in probiotic strains and technological advancements for delivering systems have improved product efficiency, stability, and shelf life, thereby providing flexible application in the sectors of beverages, snacks, and medications.
   
• The rising trend for natural and clean-label products, coupled with growing exigencies for plant-based and vegan alternatives, encourages enterprises in integrating probiotics into a wider array of eco-friendly and sustainable product formats-aligned well with the health-conscientious and environment-responsible consumption patterns of the region.
   
• The booming healthcare and wellness industry, together with therapeutic-based probiotic acceptance, are propelling the growth of the market. The demand for probiotic-based intervention is on the increase due to the escalating aged population and chromicized ill health conditions.
   

The probiotics markets in Europe, especially in a few countries like Germany, are expected to grow in the coming years, especially from 2025 to 2034, with CAGR of 8.4%.
 

• The regional drive towards probiotic products have gained traction owing to regulatory standards and increased consumer awareness of digestive health and immunity.
   
• Ongoing innovations in probiotic strains have increased their efficacy and targeted health benefits, thereby making probiotic product applications more versatility in functional foods, beverages, and nutraceuticals sustainability and eco-friendly products allows for the inclusion of probiotics into organic and clean-label product lines, in sync with the green and health-minded trends in the European marketplace.
   
• Investment in R&D, along with the growing natural and plant-based food sectors, is widening the scope of probiotic offerings, including more options in vegan and allergen-free products, hence increasing market potential.
   

The probiotics market in China and India is expected to grow rapidly between 2025 and 2034, with CAGR of 8.6% in Asia Pacific.
 

• Rapid urbanization and increasing disposable incomes are getting consumers to look for health-enhancing products, including probiotics, to be part of their daily diet.
   
• Government policies on health and wellness and measures for enhancing food safety and nutritional standards are a strong support to adopt probiotic products and promote investments in R&D and manufacturing infrastructure.
   
• Meanwhile, the supported expanding healthcare system, along with prevalent digestive and immune-related health issues, is also driving the growth of these probiotic markets in the respective countries.
   
• The increasing popularity of traditional fermented foods that are source probiotics and mixing probiotics into modern functional foods further create market opportunities complemented with consumer education and expenditures on marketing.
   

Between 2025 and 2034, the market for probiotics in the UAE and the Middle East is projected to grow significantly during this period.
 

• Expanding infrastructure, tourism, and hospitality sectors are major drivers for probiotic functional foods and dietary supplements in health and wellness initiatives.
   
• The regional-government and private-sector initiatives that encourage the promotion of healthy lifestyles and preventative healthcare further incorporate probiotics into the daily diets of the populace.
   
• The incorporation of probiotics into innovative health solutions such as personalized nutrition and clinical applications furthers the market growth in alignment with the regional agenda of sustainable and smart healthcare systems.
   

Brazil and Argentina are expected to witness growth for the probiotics sector between 2025 and 2034.
 

• Urbanization, increasing consumer health consciousness, and growing health care infrastructure have enhanced the demand for probiotic supplements and functional foods.
   
• Consumers are being encouraged to use probiotics in their diets due to growing knowledge about gastrointestinal health benefits and rising cases of gastrointestinal disorders.
   
• Government activities regarding health benefits and preventive healthcare have aided market development and raised consumer confidence in probiotic products.
   

Probiotics Market Share

• Probiotics industry is moderately consolidated with players like Yakult Honsha, Danone S.A., ADM, Kerry Group and Novonesis accounts for 22.5% market share in 2024.
   
• The probiotics market consists of such leading companies, operating mostly in their regional areas. Their long years of experience with probiotics allow these companies to maintain a strong market position worldwide. Their product offerings are diverse and majorly supported by production capacities and distribution networks, which can serve the increasing demand for probiotics in various regions.
   

Probiotics Market Companies

Major players operating in the probiotics industry includes:
 

• ADM
• Novonesis 
• Danone S.A.
• International Flavors & Fragrances
• Kaneka Probiotics
• Kerry Group
• Lallemand
• Morinaga Nutritional Foods, Inc.
• Nestlé
• Probi AB
• Sabinsa Corporation
• Sanzyme Biologics
   

Yakult Honsha is greatly enhanced by its first-mover advantage and brand recognition worldwide. The company's market success has been anchored on its long-ongoing clinical research and development on the patented strain of lactic acid bacteria, Lactobacillus casei Shirota, extensive networks for distribution from any corner of the world, and unit-to-unit consistency in product quality. Yakult has capitalized on its market leadership, especially in the Asia Pacific markets, and leveraged partnerships and direct investments to become ever-present in Europe and North America.
 

ADM's (Archer Daniels Midland Company) probiotic portfolio includes well-established strains for applications in food and dietary supplements, supported by its prolonged manufacturing infrastructure and global distribution networks. ADM approaches applications-specific probiotic solutions to food manufacturers and supplement companies by leveraging its technical expertise in ingredient formulation and processing.
 

Novonesis probiotic business engages with both food cultures for fermented products and dietary supplement applications, supported by good quality management systems and regulatory compliance expertise. Its competitive advantage relies on its scientifically approved method of strain selection and characterization with focus on clinically proven health benefits and stability to withstand different processing conditions.
 

Danone S.A. benefitting from its large global dairy platform integrates probiotic formulations across several consumer product categories with particular strength in functional yogurt and fermented dairy products. Its probiotic strategy focuses on clinically documented strains with verified health claims, primarily in the area of digestive health and immune function. 
 

Kerry Group plc maintains its considerable presence through the functional ingredients division, providing probiotics sources, and formulation support to food and beverage manufacturers worldwide. This has enabled them to emphasize solutions and technical support services focused on application-specific solutions that help their customers successfully integrate probiotics into their product formulations.
 

Probiotics Industry News

• In March 2025, IFF announced the further use of the Enviva PRO probiotic for pigs, demonstrating its effects on gut health, growth performance, and reduced diarrhea in post-weaning piglets to promote swine welfare and production efficiency.
   
• In October 2023, Nestlé announced its innovative Sinergity blend, a specific probiotic strain with HMOs to promote infant development and strengthen gut microbiota and immunity in early life, thus maintaining Nestlé's leadership in science-based early nutrition.
   
• March 2023, Danone launched Almimama in Spain, a probiotic supplement designed to support breastfeeding by lowering mastitis risk. Based on breastmilk research, it combined L. salivarius PS2 with FOS to promote health in the mother.
   
• In February 2023, ADM opened a new facility in Valencia, with an investment of more than USD 30 million to increase the production capabilities of probiotics and postbiotics to meet rising global demand and support wellness markets across the globe.
   

The probiotics market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Billion and volume in terms of Kilo Tons from 2021 to 2034 for the following segments:

Market, By Ingredients

• Bacterial probiotics
  • Lactobacillus 
  • Bifidobacterium 
  • Bacillus 
  • Others 
• Yeast probiotics
  • Saccharomyces boulardii
  • Saccharomyces cerevisiae
  • Others

Market, By Application

• Human dietary supplements
  • Capsule & tablet
  • Powder & liquid supplement
  • Gummy & chewable 
• Functional foods & beverages 
  • Dairy-based probiotic products 
  • Yogurt & fermented milk
  • Cheese & dairy
  • Plant-based & non-dairy alternatives
  • Probiotic beverages & functional drinks
  • Fortified food applications
  • Breakfast cereals & nutrition bars
  • Baked goods & confectionery
  • Frozen & processed foods
• Animal nutrition & feed applications
  • Livestock feed additives 
  • Poultry 
  • Companion animal
• Pharmaceutical & medical products
  • Live biotherapeutic products
  • Prescription probiotic medications
  • Medical foods & clinical nutrition
• Others

Market, By End Use Industry

• Food & beverage manufacturing
  • Dairy processing 
  • Functional food manufacturers
  • Organic & natural product 
• Pharmaceutical & biotechnology
• Animal agriculture & feed 
• Consumer health & wellness
• Others

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe 
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa